COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-03208-0002-0000-7
Chemical Name: tert-Butyl perbenzoate
CASRN: 614-45-9
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 096324_CA
Study Result: Positive

Study Result: Positive
Activation Trial Trial Call
No Activation  Positive 
Induced Rat Liver S9  1_S9  Positive 
No Activation  Positive 

Trial #:1   Activation: No Activation    Date: 08/09/1984    Harvest Time: 12.5 hour(s)   Trial Call: Positive   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
100 1 0.010 1.0 0 0.000 0.0 1 0.010 1.0 0 0.000 0.0
Test Chemical: tert-Butyl perbenzoate
5         
100 9 0.090 9.0 3 0.030 3.0 6 0.060 6.0 0 0.000 0.0
10         
100 42 0.420 31.0 26 0.260 23.0 16 0.160 13.0 0 0.000 0.0
Positive Control: Mitomycin-C
 0.25      
100 33 0.330 27.0 22 0.220 20.0 11 0.110 11.0 0 0.000 0.0
Mitomycin-C
1         
50 32 0.640 50.0 27 0.540 42.0 5 0.100 10.0 0 0.000 0.0
Trend: 6.180 6.240 3.110  
Probability: 0.000 0.000 0.001  


Trial #:1_S9   Activation: Induced Rat Liver S9    Date: 08/08/1984    Harvest Time: 13 hour(s)   Trial Call: Positive   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
100 1 0.010 1.0 0 0.000 0.0 1 0.010 1.0 0 0.000 0.0
Test Chemical: tert-Butyl perbenzoate
10         
100 6 0.060 5.0 2 0.020 2.0 4 0.040 4.0 0 0.000 0.0
16         
100 9 0.090 9.0 3 0.030 3.0 5 0.050 5.0 1 0.010 1.0
30         
100 15 0.150 14.0 10 0.100 9.0 5 0.050 5.0 0 0.000 0.0
50         
100 22 0.220 20.0 14 0.140 13.0 8 0.080 8.0 0 0.000 0.0
100         
34 26 0.765 26.0 13 0.382 21.0 2 0.059 6.0 11 0.324 2.0
Positive Control: Cyclophosphamide
15         
100 45 0.450 38.0 32 0.320 27.0 13 0.130 13.0 0 0.000 0.0
Trend: 5.612 5.518 2.119  
Probability: 0.000 0.000 0.017  


Trial #:2   Activation: No Activation    Date: 03/13/1985    Harvest Time: 17.5 hour(s)   Trial Call: Positive   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
100 3 0.030 3.0 1 0.010 1.0 2 0.020 2.0 0 0.000 0.0
Test Chemical: tert-Butyl perbenzoate
5         
100 26 0.260 23.0 5 0.050 5.0 20 0.200 18.0 1 0.010 1.0
10         
100 38 0.380 32.0 24 0.240 20.0 14 0.140 14.0 0 0.000 0.0
Positive Control: Mitomycin-C
 0.125     
100 26 0.260 21.0 11 0.110 9.0 15 0.150 14.0 0 0.000 0.0
Mitomycin-C
 0.25      
50 19 0.380 22.0 14 0.280 18.0 5 0.100 8.0 0 0.000 0.0
Trend: 3.928 4.934 1.030  
Probability: 0.000 0.000 0.151